18th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies
View More
Medical Crossfire® in Adjunctive Testing: Charting a New Course in Prostate Cancer Risk Assessment
Safety, efficacy of vibegron sustained in men with OAB treated for BPH
FDA updates in urology: April 2025
Pearls & Perspectives: Future of reconstructive urology, with Ryan Terlecki, MD, at AUA 2025
TAR-200 boasts impressive DFS rates in papillary disease-only NMIBC
